Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Coram (CRH)--has the turnaround begun -- Ignore unavailable to you. Want to Upgrade?

To: leigh aulper who wrote (21)	5/19/1998 4:29:00 PM
From: Lou Little	Respond to of 85

hemophilia contract Good news for CRH. This traditionally has been one of the most profitable therapy segments for the infusion business. Very little service required (many programs ship cross country, contracting what little nursing service may be required). Many drugs sell at significant discounts to AWP. For contracts whose price is based on AWP, this can be really profitable. wonder why the price keeps going down? oh yeah, they still need to show they can "get the red out".